Consumers, unions charge PBMs with deceiving plans and patients

The campaign for hand eczema is the latest in a number of high-cost campaigns to raise awareness of dermatological conditions.

Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.

Identifying what is truly treatment resistant depression is difficult given all the factors that may influence how a person responds to treatment.

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.

Kennedy's vaccines may give some Republican senators pause while Oz has an ally in Medicare Advantage plans.

After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.